Symptoms at admission to Altai coMra Center:

The patient - female, 60 - complained of:

• constant increase of the glucose level in the blood during the day, going up to 19-22 mmol/L and this despite the regular intake of glycemic medications;
• sense of weakness, malaise, depression, dry mouth and thirst;
• deteriorated sight, in particular hemorrhage in the left eye since yesterday;
• increased urination at night: up to 4-5 times.

The patient shared that the current state of her body somewhat affects her ability to work and be active during the day. She decided to take a leave from her work during the treatment period.

History of the disease:

The patient was diagnosed more than 25 years ago. She regularly takes all prescribed medications for the main and concomitant diseases and she is monitored by medical doctors.

She keeps Pevzner Diet No 9 for most of the time, but at times she temporarily fails it.

She is periodically examined at the local clinic by a physician and endocrinologist and she checks her glucose level daily, usually in the morning, by a glucometer.

General state at admission:

The patient was admitted in good general condition and good mood.

However, she was overweight with morbid obesity with excess fatty tissue in the abdomen and thighs. (BMI = 42)

Diagnosis:

1. Main Diagnosis:

• Diabetes mellitus Type 2. The target blood glucose levels (up to 7.8 mmol/L at present) has not been achieved.
• Diabetic sensory neuropathy of the lower extremities.
• Diabetic retinopathy in both eyes.
• Diabetic nephroangiopathy.
• 3^d degree morbid obesity. (BMI = 42)

2. Other Diseases:

• Subconjunctival hemorrhage of the left eye (since the previous day).
• Chronic pyelonephritis in latent inflammation.
• Chronic cholecystitis, remission.
• Hypertension.

3. Rehabilitation Diagnosis:

• Persistent malfunction of all forms of metabolism due to the prolonged course of the main disease.
• Frequent complications of the main disease with high risk for the general health and life.
• Periodic manifestation of neurosensory and nephroangipathic syndrome.
• Partial obstruction of the labour and social activity by the weakness and malaise, but still going to work.
• Lessening of the clarity of sight due to subconjunctival hemorrhage of the left eye and the frequent complications of the main disease.

Treatment:

1. Treatment Goals:

Based on the wishes of the patient, the judgement of the MD, and the possibilities of patient's body, the aim of the first treatment course was set at:

1. Short term goals:
   • stabilisation of the readings of blood glucose during the twenty-four hours closer to the target level, so that the intake of medications may be reduced (the latter being patient's main wish);
   • removing the consequences of the hemorrhage in the left eye;
   • removing or decreasing the sense of weakness, malaise, depression, dry mouth and thirst;
   • decreasing the frequency of night urination to 1,2 times per night.
2. Long term goals:
   • stabilisation (normalisation) of the function of the pancreas - this function should exit the critical operational mode and balance within the general energetic and metabolic exchange during the twenty-four hours and longer periods in accordance with the bodily rhythm;
   • normalisation of the excretory function of the intestines and digestive glands;
   • partial restoration of the regenerative abilities of the cells of the pancreas (in this course it is the restoration of the internal and external function of the cell, partial or complete replacement of structures and elements in the cell), after the prolonged inflammatory reaction and inhibition of cell functions;
   • improving the quality of life and stabilizing concomitant diseases by reducing clinical manifestations.

2. Treatment at Altai coMra Center:

The first coMra Therapy Treatment Course consisted of 11 treatment sessions for 7 days: 1 treatment session on days 1, 6 and 7, and 2 treatment session per day on days 2-5. Each treatment session consisted of:

• Endocrinology 1;
• Gastroenterology 7;
• Universal 3;
• Left eye: for 5 minutes at 50 Hz and for 5 minutes at 1000 Hz.

3. Home Treatment:

It was recommended to the patient to continue taking her prescribed medications:

• Metformin, twice a day (morning and evening) 1000 mg each time;
• Gliclazide, twice a day (morning and evening) 30 mg each time;

It was also explained to the patient that during the coMra treatment period she could reduce her doses, provided blood glucose normalises.

Results:

After the first Treatment Course the patient reported great improvement of her condition:

1. During the treatment and while the patients was taking the same medicines and in the same dozes as before, the glucose in the blood normalised to 8-11 mmol/L (versus 19-22 mmol/L before) ;
2. dry mouth and thirst disappeared;
3. the consequences of hemorrhage in the left eyeball passed by day 4, with restoration of the natural color of the albumin of the eye;
4. urination at night normalised - up to 1-2 times per night vs 4-5 times previously;
5. the patient mentioned also: normalisation of blood pressure: up to 130/80 mm Hg (versus 140-150/90 mm Hg previously); sleep returned to normal, depression passed.

Conclusion:

The short term goals of the first Treatment Course were fully achieved, see Results, pts.1-4, and the regeneration processes comprising the long-term goals have partially started to take place: Results, pt.5.

After the first Treatment Course the patient was advised to:

1. coMra Therapy:
   • Repeat this Treatment Course after 1 or 2 weeks: 11 more treatment sessions;
   • then 3 weeks break and then do the full course: 22-24 sessions no breaks.
   • Ideally, do this Course once or twice per quarter.
2. start reducing the dose of medication slowly and consistently by 1/4 of the initial dose for 5-7 days under careful monitoring of daily blood glucose levels.

Follow-up:

• The effect achieved during this course of coMra therapy lasted until the next course.
• The patient underwent 2 more courses - one after 3 weeks and one after 6 months. Both consisted of 11-15 sessions.
• The general condition improved significantly during this time, the doses of the drugs were reduced to of the initial dosage and only metformin 500 mg twice a day (morning and evening) was left for permanent use.
• The patient subsequently took courses periodically and for preventive purposes (she did not want to radically change anything else in her lifestyle and attitude to the disease).